After opposition, Bionomics wants to amend its patent
Following a legal opposition against their European patent (EP 1364025), which claims genetically engineered chimpanzees as an „invention“, the Australian company Bionomics has decided to relinquish the controversial claims. The patent will therefore no longer cover genetically modified animals. In July 2013, the European Patent Office (EPO) granted Bionomics the patent covering animals such as pigs, sheep, dogs, cats and even chimpanzees. According to the patent, the animals were to be manipulated with human gene sequences associated with carcinogenesis.
Testbiotech warns that the planned free trade agreement TTIP will endanger freedom of choice
Today the German parliament is likely to vote in favour of a permanent prohibition against the cloning of animals for food production. The German government will also be urged to push for EU-wide labelling that extends to the offspring of cloned animals and food products. Testbiotech welcomes this initiative but raises doubts about its ultimate success, since the planned free trade agreement TTIP is likely to diminish any room left for political decision making.
New documents show Monsanto does not comply with EU regulations
As several documents from Monsanto, the EU Commission and European Food Safety Authority EFSA show, cultivation of genetically engineered maize MON810 does not comply with EU regulations. The main problem is the legally required monitoring of potentially adverse environmental effects. There is also new evidence that the environmental risk assessment for MON810 carried out by EFSA was based on flawed assumptions. Maize MON810 is the only genetically engineered crop authorised for cultivation in the EU.